Finance

Beta
Lists
EWTX:NASDAQ
Edgewise Therapeutics Inc
$36.93
+0.33%
(+0.12) 1D
Jun 22, 2:12:47 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EWTX...
Open
$37.51
High
$37.51
Low
$35.96
Mkt. cap
3.97B
Avg. vol.
1.58M
Volume
546.80K
52-wk high
$40.76
52-wk low
$12.15
EPS
-$1.66
Beta
0.27
Shares outstanding
107.59M
No. of employees
154
Open
$37.51
High
$37.51
Low
$35.96
Mkt. cap
3.97B
Avg. vol.
1.58M
Volume
546.80K
52-wk high
$40.76
52-wk low
$12.15
EPS
-$1.66
Beta
0.27
Shares outstanding
107.59M
No. of employees
154
Analyst outlook
Analyst Ratings
Based on 11 analysts giving stock ratings to EWTX in the past 3 months
Strong Buy
Buy
9
Hold
2
Sell
0
12 month forecast
Based on 11 Wall Street analysts offering 12 month price targets for EWTX in the last 3 months.
Highest
Current $36.93
$66.00 (+78.72%)
Average
$49.44 (+33.87%)
Lowest
$32.00 (-13.35%)
News stories
From sources across the web
About Edgewise Therapeutics Inc
CEO-
Employees154
Founded2017
HeadquartersBoulder, Colorado, United States
SectorPharmaceutical industry
Websiteedgewisetx.com
Analyst Ratings
Based on 11 analysts giving stock ratings to EWTX in the past 3 months
Strong Buy
Buy
9
Hold
2
Sell
0
12 month forecast
Based on 11 Wall Street analysts offering 12 month price targets for EWTX in the last 3 months.
Highest
Current $36.93
$66.00 (+78.72%)
Average
$49.44 (+33.87%)
Lowest
$32.00 (-13.35%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Laura Chico
Wedbush
Buy
Maintained
$52.00
+40.8%
06/17/2026
Srikripa Devarakonda
Truist Financial
Buy
Maintained
-
-
06/17/2026
Leonid Timashev
RBC Capital
Buy
Reiterated
$59.00
+59.8%
06/17/2026
Debjit Chattopadhyay
Guggenheim
Buy
Maintained
$41.00
+11%
06/17/2026
Paul Choi
Goldman Sachs
Hold
Reiterated
$32.00
-13.3%
06/17/2026
Joseph Schwartz
Leerink Partners
Buy
Reiterated
$52.00
+40.8%
06/16/2026
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
$45.00
+21.9%
06/16/2026
Tessa Romero
J.P. Morgan
Buy
Reiterated
$53.00
+43.5%
06/05/2026
Unknown Analyst
Guggenheim
Buy
Maintained
$41.00
+11%
06/02/2026
Martin Auster
Raymond James
Buy
Reiterated
$66.00
+78.7%
06/01/2026
James Condulis
Stifel Nicolaus
Hold
Maintained
-
-
06/01/2026
Unknown Analyst
Goldman Sachs
Hold
Maintained
$20.00
-45.8%
05/11/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
$45.00
+21.9%
05/08/2026
David Nierengarten
Wedbush
Buy
Maintained
$46.00
+24.6%
05/08/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$51.00
+38.1%
02/09/2026
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.46 / -$0.48
+3.72%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
33.56M
37.48M
43.59M
42.65M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.05M
9.38M
12.38M
11.46M
Operating expense
42.61M
46.86M
55.98M
54.12M
Total operating expenses
42.61M
46.86M
55.98M
54.12M
Operating income
-42.61M
-46.86M
-55.98M
-54.12M
Other non operating income
-
-
-
-
EBT including unusual items
-36.12M
-40.67M
-50.22M
-49.01M
EBT excluding unusual items
-36.12M
-40.67M
-50.22M
-49.01M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-36.12M
-40.67M
-50.22M
-49.01M
Net profit margin
-
-
-
-
Earnings per share
-0.34
-0.39
-0.47
-0.46
Interest and investment income
6.50M
6.19M
5.76M
5.10M
Interest expense
-
-
-
-
Net interest expenses
6.50M
6.19M
5.76M
5.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
-42.09M
-46.34M
-55.45M
-53.58M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer